Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Aug 06, 2021 7:16am
98 Views
Post# 33662360

RE:RE:RE:RE:RE:RE:RE:RE:Dose escalation

RE:RE:RE:RE:RE:RE:RE:RE:Dose escalation

The board has gone from speculating on the oncology platform to fantasising.....

Reminder ..... This is only a few months in  Phase 1 in first in human testing and ZIP has so far been reported .... I also witnessed big smile in Beliveau and Paul and Marsolais but this reminds me of Spceo reporting more than 2 years ago after a phone call with Dubuc and Tanguay that he had not learned anything new but he could feel what he called A PEP IN THE STEP.... in their attitude...

The good news is the trial is still ongoing... but that is all we know
 

qwerty22 wrote:

They mostly remain pretty contained with their statements so it's not too difficult to stay honest. They've essentially said nothing about the on going trial. This board has a tendency to take those contained statements and blow them up with all sorts of hidden meaning. Just think how much has been read into that nothing!

(I'm not saying I'm not guilty too)

 

Bucknelly21 wrote: Paul seems extremely confident to me I think he has to be honest

 

 



<< Previous
Bullboard Posts
Next >>